TS-036654 — A nanoparticle approach for achieving stent-free restenosis treatment following angioplasty
Around 3.2 million stent procedures are performed annually worldwide to treat cardiovascular diseases. However, up to 50% of the reconstructed vessels, particularly those in the periphery, fail due to re-narrowing, or restenosis. Current anti-restenotic treatments with drug-eluting stents (DES) do…
